Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Feb 2021 - 31 Jul 2021 | 25 Aug 2021 | 41 | 19% | 74% | 7% | 81% |
| 01 Aug 2020 - 31 Jan 2021 | 30 Mar 2021 | 40 | 21% | 73% | 6% | 74% |
| 01 Feb 2020 - 31 Jul 2020 | 24 Aug 2020 | 41 | 13% | 79% | 8% | 86% |
| 01 Aug 2019 - 31 Jan 2020 | 03 Mar 2020 | 43 | 12% | 83% | 6% | 88% |
| 01 Aug 2018 - 31 Jan 2019 | 11 Mar 2019 | 23 | 83% | 16% | 2% | 18% |
| 01 Jan 2018 - 30 Jul 2018 | 14 Dec 2018 | 27 | 58% | 40% | 2% | 42% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
30 days from invoice date
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
30
Any disputes on individual invoices are raised in the first instance to the finance email box or by phone to the finance team. They will work with the supplier to resolve the issue. WE aim to resolve issues raised by suppliers within 5 working days, but we typically respond the next working day. Any contractual disputes are managed though our commercial contract management process.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Immunocore Limited is the UK operating entity within the Immunocore group, based at Milton Park, Abingdon, and registered for research and experimental development on natural sciences and engineering. The wider group, headed by Immunocore Holdings plc, is a commercial-stage biotechnology business that discovered, developed and commercialised the world's first approved T cell receptor (TCR) therapy. Its proprietary ImmTAX platform produces bispecific TCR therapies designed to activate the immune system against cancer and infectious diseases, or to reduce it in autoimmune conditions. The group operates a pipeline of such therapies alongside its approved product, with additional offices in the US, Ireland and Switzerland, while the Oxfordshire entity forms part of this research and development operation.
Generated from the company's website and Companies House records. Sources: immunocore.com · immunocore.com